Abstract

Nicotinamide adenine dinucleotide (NAD) is a profoundly important cofactor in redox reactions. Nicotinamide phosphoribosyltransferase (NAMPT) and nicotinate phosphoribosyltransferase (NAPRT) are key enzymes for NAD salvage biosynthesis pathway, which reciprocally synthesize NAD to supply the main source of NAD biosythesis. However, the prognostic value of NAMPT and NAPRT in colorectal cancer (CRC) remains largely unknown. Our present study detected NAMPT and NAPRT protein expression in cancer and adjacent tissues from 261 CRC using immunohistochemical staining. We found that high expression of NAMPT or NAPRT was associated with vascular invasion, invasion depth and advanced TNM stage in CRC. High expression of NAMPT or NAPRT predicts short overall survival and disease-free survival time in CRC patients, which were further confirmed by public datasets. Furthermore, positive correlation between expression of NAMPT and NAPRT was revealed in CRC tissues and cell lines. NAPRThigh/NAMPThigh patients tended to have the shortest survival time. Using the TCGA RNA-sequencing data, we showed that gene amplification, mutation, and methylation of NAPRT are more common than NAMPT. On the other hand, NAMPT gene might be targeted by more miRNAs. Finally, genes that are correlated with NAPRT or NAMPT are enriched in different pathways. In conclusion, we found that high expression of NAMPT or NAPRT predicts poor prognosis of CRC patients, but the regulatory mechanism might be distinct from each other.

Highlights

  • Colorectal cancer (CRC) is the third most common malignant tumor in the world, and death from colorectal cancer (CRC) accounts for 9.2% of cancer-related deaths [1]

  • We found that the expression of nicotinate phosphoribosyltransferase (NAPRT) in CRC tissues was dramatically higher than adjacent tissues (Figure 1B), which increased as TNM stage advanced (Figure 1C)

  • Univariate Cox regression analysis showed that high NAPRT expression was prognostic risk factor for disease-free survival (DFS) (hazard ratio (HR) = 2.765, 95% confidence interval (CI) = 1.468–5.210, P = 0.002) and overall survival (OS) (HR = 2.622, 95% CI = 1.459–4.713, P = 0.001) (Table 2)

Read more

Summary

Introduction

Colorectal cancer (CRC) is the third most common malignant tumor in the world, and death from CRC accounts for 9.2% of cancer-related deaths [1]. The treatment of CRC is challenging due to the complexity of its pathogenesis. Recent studies have shown that nicotinamide adenine dinucleotide (NAD) metabolism plays a major role in the progression of CRC [2]. NAD, as an essential co-enzyme, mediates redox reactions in various metabolic pathways, including glycolysis, tricarboxylic acid cycle, oxidative phosphorylation, and serine biosynthesis. NAD functions as an important element for many signaling pathways by affecting the activity of several enzymes such as sirtuins (SIRTs) and poly(adenosine diphosphate [ADP]-ribose) polymerases (PARPs).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call